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Rare kidney diseases encompass several different conditions, most of which are inherited. 
Although individual rare kidney diseases raise specific issues, as a group these rare diseases 
can present overlapping challenges in diagnosis and treatment. These challenges include 
small numbers of affected patients, unidentified causes of disease, lack of biomarkers for 
monitoring disease progression, and need for complex care.  
The definition of rare diseases varies across the world. In Europe, a disease or disorder is 
defined as rare when the prevalence is <1 in 2,000 individuals, whereas in the USA, the 
designation of a rare disorder applies when <200,000 Americans are affected.  
Rare kidney diseases include more than 150 different conditions. The majority are inherited, 
while others, such as the primary glomerulonephritides, have complex etiologies. For 
inherited kidney disorders, diagnosis, management, and treatment are complex, es pecially 
when they are associated with multisystem complications. Patients often waste years 
visiting multiple health care providers before receiving an accurate diagnosis. Advances in 
kidney replacement therapy and its increased access allow prolonged patient survival, yet 
often with a poor quality of life. In particular, children born with severe congenital 
nephropathies face a high likelihood of altered physical, cognitive, and psychosocial 
development.  
Therapeutic advances in rare kidney diseases have been hindered by several factors, 
including unidentified genetic defects, lack of biomarkers to monitor disease progression, 
heterogeneous clinical phenotypes, and outdated diagnostic classifications that do not 
reflect the  underlying pathophysiological mechanisms. Many initiatives have focused on 
rare kidney diseases, and regulations have been created to promote the development of 
therapies, organize optimal health care systems, and encourage research. Patient 
organizations have also taken a leading role in these matters. Together, technological 
advances and organized advocacy have helped enhance our understanding of the clinical, 
genetic, and mechanistic issues in many inherited kidney disorders. 
Among others, it is worth noting that in March, 2017, the European Reference Network for 
rare kidney diseases (www.erknet.org) was set up together with 23 other rare disease 
networks during a conference in Vilnius, LT. The European Commission  thus finally 
recognized the eminent importance of improving the clinical management of patients 
suffering from rare diseases. Studies have shown that currently,  establishing diagnosis of 
these diseases is delayed on average by 5 years thereby creating considerable uncertainty 
for patients and their families. Furthermore, there is an enormous lack of effective therapies 
compared with more prevalent diseases. 
 
This new Topical Collection of the Journal of Nephrology on rare and complex kidney 
diseases aims to provide an updated overview on the incredible scope of research of this 
thriving kidney research field, thus attesting to the significant progress that has been made 
towards improving the medical management of patients suffering from these genetic, 
autoimmune/autoinflammatory and metabolic diseases of the kidney.  
The Topical Collection will involve diagnostic challenges, management of kidney function 
decline and progression of chronic kidney disease, translation of advances in research to 
clinical care, and provision of practical and integrated patient support.  Here, we wi ll collect 
cutting-edge original studies and expert reviews on selected genetic and autoimmune 
diseases that nicely illustrate both recent research progress at this fast‐moving experimental 
nephrology frontier and the many open questions that we are still facing. 
 
 
 
